Hanx Biopharmaceuticals (Wuhan) Co., Ltd.
2 clinical trials · Sponsor
◉ Watch Hanx Biopharmaceuticals (Wuhan) Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Clinical Study of HX111 in Patients With Advanced Solid Tumor and Lymphoma (NCT07333469) | Hanx Biopharmaceuticals (Wuhan) Co., Ltd. | 2026-01-19 |
| HX044,FIH Study in Patients with Advanced Solid Tumor Malignancies (NCT06649708) | Hanx Biopharmaceuticals (Wuhan) Co., Ltd. | 2024-12-30 |
Track Hanx Biopharmaceuticals (Wuhan) Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.